Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > No trades

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Jun 02, 2021 10:33am

95 Views

Post# 33310351

RE:No trades

Remarkable! Take a look at another Montreal based drug company, Sunshine Biopharma (SBFM). It has literally nothing at all that should attract investors who spend any time looking at it closely (pre-clinical cancer drug and nothing more than a prayer on a pre-clinical covid drug) and a disastrous balance sheet. It trades on the OTC pink sheets for $0.19 per share and has traded over 1 million shares today. It traded over 8 million shares yesterday. Clearly, we are at a nutty place with the current markets where such nonsense does go on, but zero trading for a real company versus over 1 million shares traded for a fake one is seemingly impossible, but it is not because it happened this morning.